ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 66 filers reported holding ALDEYRA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $345,336 | -27.4% | 51,697 | -8.8% | 0.00% | 0.0% |
| Q2 2023 | $475,814 | +411.6% | 56,712 | +170.6% | 0.00% | – |
| Q1 2022 | $93,000 | -11.4% | 20,956 | -20.0% | 0.00% | – |
| Q4 2021 | $105,000 | -54.3% | 26,203 | 0.0% | 0.00% | – |
| Q3 2021 | $230,000 | -69.7% | 26,203 | -60.9% | 0.00% | -100.0% |
| Q2 2021 | $759,000 | +772.4% | 66,960 | +90.6% | 0.00% | – |
| Q1 2020 | $87,000 | -56.9% | 35,132 | +1.2% | 0.00% | – |
| Q4 2019 | $202,000 | +10.4% | 34,724 | 0.0% | 0.00% | – |
| Q3 2019 | $183,000 | -12.0% | 34,724 | 0.0% | 0.00% | – |
| Q2 2019 | $208,000 | -30.4% | 34,724 | +5.0% | 0.00% | -100.0% |
| Q1 2019 | $299,000 | +9.1% | 33,068 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $274,000 | -18.5% | 33,068 | +35.7% | 0.00% | 0.0% |
| Q3 2018 | $336,000 | +73.2% | 24,369 | 0.0% | 0.00% | – |
| Q2 2018 | $194,000 | – | 24,369 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 3,031,915 | $20,253,192 | 21.02% |
| Perceptive Advisors | 11,350,085 | $75,818,568 | 2.53% |
| JOHNSON & JOHNSON | 394,834 | $2,637,491 | 0.97% |
| Joseph P. Lucia & Associates, LLC | 28,331 | $189,251 | 0.13% |
| WOODSTOCK CORP | 137,179 | $916,356 | 0.12% |
| Palo Alto Investors LP | 160,800 | $1,074,144 | 0.10% |
| Affinity Asset Advisors, LLC | 44,348 | $296,245 | 0.08% |
| Verition Fund Management LLC | 935,273 | $6,247,624 | 0.07% |
| FOX RUN MANAGEMENT, L.L.C. | 33,519 | $223,907 | 0.07% |
| TOBIAS FINANCIAL ADVISORS, INC. | 34,173 | $228,276 | 0.06% |